These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 20395520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome.
    Greco TP, Conti-Kelly AM, Greco T, Doyle R, Matsuura E, Anthony JR, Lopez LR.
    Am J Clin Pathol; 2009 Oct; 132(4):613-20. PubMed ID: 19762540
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease.
    Bliden KP, Chaudhary R, Lopez LR, Damrongwatanasuk R, Guyer K, Gesheff MG, Franzese CJ, Kaza H, Tantry US, Gurbel PA.
    Am J Cardiol; 2016 Sep 01; 118(5):673-8. PubMed ID: 27401271
    [Abstract] [Full Text] [Related]

  • 6. The oxidized low-density lipoprotein/β2-glycoprotein I complex is associated with abdominal obesity in healthy middle-aged men.
    Kraml PJ, Syrovátka P, Potočková J, Anděl M.
    Ann Nutr Metab; 2013 Sep 01; 62(1):7-13. PubMed ID: 23171597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Sep 01; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ, Han AZ, Meng Y, Gong JB, Zhang CN, Li K, Liu YX.
    Clin Biochem; 2010 Apr 01; 43(6):571-5. PubMed ID: 20060390
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P, Veres K, Laczik R, Der H, Csipo I, Timar O, Szomjak E, Szegedi G, Szodoray P.
    Thromb Haemost; 2007 Aug 01; 98(2):413-9. PubMed ID: 17721625
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun 01; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 17. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Jun 01; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.